Hyperammonaemia is associated with hospitalisation for bacterial infection: A multicentre cohort study
BACKGROUND AIMS: Hyperammonaemia is traditionally linked to overt hepatic encephalopathy (OHE), but growing evidence suggests it also contributes to cirrhosis-associated immune dysfunction. We evaluated the association between plasma ammonia and bacterial infection and compared ammonia, the AMMON-OHE model and prognostic scores for predicting bacterial infection and other liver-related events in outpatients with cirrhosis. APPROACH RESULTS: This is a multicentre, retrospective study in 1855 cirrhosis patients on prospectively followed cohorts from five European and one Singaporean centres. The primary endpoint was hospitalisation with bacterial infection. Within one year, 8% of European patients developed infection; these patients had higher ammonia (1.75 vs. 0.97 times ULN; p<0.001) and a sevenfold higher risk of liver-related death (37% vs. 5%; p<0.001). Ammonia remained associated with infection, each unit increase raising risk by 12-14%, and was selected by every variable-selection method. The 1.4 times ULN threshold identified patients at increased risk of infection and OHE (both p<0.001). Ammonia alone discriminated well for infection (C-index 0.725 in Europe, 0.877 in Singapore), and integration into the AMMON-OHE model improved prediction (C-index 0.805 in Europe), with good calibration and clinical utility comparable to Child-Pugh and greater than MELD. Both also predicted OHE (C-index up to 0.904), whereas performance was weaker for ascites and variceal bleeding. CONCLUSION: Hyperammonaemia is associated with hospitalisation due to bacterial infection and predicts both infection and OHE. These findings support an ammonia-related vulnerability phenotype characterised by immune dysfunction and neurocognitive susceptibility, for which the AMMON-OHE model provides individualised risk stratification.
Authors
- Mattias Mandorfer (ORCID: https://orcid.org/0000-0003-2330-0017)
- Paloma Poyatos
- Rahul Kumar (ORCID: https://orcid.org/0000-0002-5092-4821)
- Juan Antonio Carbonell‐Asins (ORCID: https://orcid.org/0000-0002-8449-5674)
- Juan José Gallego (ORCID: https://orcid.org/0000-0002-9340-1641)
- Javier Ampuero (ORCID: https://orcid.org/0000-0002-8332-2122)
- Paloma Lluch (ORCID: https://orcid.org/0000-0003-3192-3820)
- Carmina Montoliú (ORCID: https://orcid.org/0000-0002-4740-4788)
- Rajiv Jalan (ORCID: https://orcid.org/0000-0002-7747-4015)
- Thomas Henry Tranah (ORCID: https://orcid.org/0000-0001-9290-3044)
- Salvador Benlloch (ORCID: https://orcid.org/0000-0002-0794-6937)
- María Pilar Ballester (ORCID: https://orcid.org/0000-0001-7177-5696)
- Thomas Reiberger (ORCID: https://orcid.org/0000-0002-4590-3583)
- Rakhi Maiwall (ORCID: https://orcid.org/0000-0003-0110-5982)
- Gayathry Morvil
- Karen Louise Thomsen (ORCID: https://orcid.org/0000-0002-8118-4643)
- Lorenz Balcar (ORCID: https://orcid.org/0000-0002-6708-3061)
- Loi Pooi Ling
- José Sánchez
- Manuel Romero-Gómez (ORCID: https://orcid.org/0000-0001-8494-8947)
- Debbie L. Shawcross
- Yelko Bejarano
Institutions
- Universitat de València (ES)
- King's College London (GB)
- Universidad Cardenal Herrera CEU (ES)
- The Royal Free Hospital (GB)
- Changi General Hospital (SG)
- Aarhus University Hospital (DK)
- Hospital Clínico Universitario de Valencia (ES)
- European Foundation for the Study of Chronic Liver Failure (ES)
- Hospital Arnau de Vilanova (ES)
- Institute of Liver and Biliary Sciences (IN)
- Instituto de Biomedicina de Sevilla (ES)
- Hospital Universitario Virgen del Rocío (ES)
- INCLIVA Health Research Institute (ES)
- University College London (GB)
- Medical University of Vienna (AT)
- Universidad de Sevilla (ES)
Publication Details
- Journal
- Hepatology
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1097/hep.0000000000001919
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00